Total Funding
70
44
Total FundingSeries C raised
Growth Score
-19 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
31085
Cutiss is a life science company that engages in regenerative medicine production, skin tissue engineering, and curated therapy solutions.
- Daniela Marino: CEO
- Fabienne Hartmann-Fritsch: CCO and Co-Founder
About the Company
Cutiss AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin is expected to result in a minimally scarring outcome after transplantation. denovoSkin received a Swissmedic, EMA and FDA
Orphan drug designation for the treatment of burns.
